2026-01-19 - Analysis Report
### English Report: Intuitive Surgical (ISRG) Stock Analysis
### Overview
Intuitive Surgical is a company that manufactures da Vinci surgical systems for robotic-assisted surgery.

### Return Rate Comparison (rate vs S&P 500)
- **Rate (ISRG):** 82.66%
- **Rate (VOO):** 82.54%
- **Divergence:** N/A

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|--------|
| 2016-2018  | 9.0% | 16.0% | 9.0% | 1.2  | 57.2B  |
| 2017-2019  | 7.0% | 16.0% | -2.0% | 1.4  | 70.7B  |
| 2018-2020  | 10.0% | 20.0% | -11.0% | 1.2  | 97.8B  |
| 2019-2021  | 45.0% | 20.0% | 7.0%  | 1.2  | 128.8B |
| 2020-2022  | 30.0% | 37.6% | 20.0% | 1.2  | 95.1B  |
| 2021-2023  | 48.0% | 37.6% | 31.0% | 1.4  | 121.0B |
| 2022-2024  | 58.0% | 34.3% | 31.0% | 1.3  | 187.1B |
| 2023-2025  | 63.0% | 20.7% | 14.0% | 1.2  | 203.1B |

### Recent Stock Price Fluctuations
- **Close:** $535.00
- **Last-Market:** $535.07 (previous close: $541.27, change: -1.15%)
- **5-day SMA:** $551.53
- **20-day SMA:** $570.17
- **60-day SMA:** $560.99

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence
- **Market Risk Indicator (MRI):** 0.80 (high investment recommended)
- **RSI:** 29.97
- **PPO:** -0.99
- **Hybrid Signal:** Buy (Cash: 22%)
- **Risk Level:** Medium
- **Recent (20 days) relative divergence change:** 0.0 (flat)
- **7-day Rank change:** 0 (flat)
- **7-day Dynamic Expected Return change:** 0.0 (flat)

### Recent News & Significant Events
- Recent headlines suggest that ISRG stock fell despite strong Q4 procedure growth and revenue beat.
- Analysts and investors are discussing the sharp decline in the stock price.

### Analyst Opinions:
- **Analyst Consensus:** 
  Buy
  Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
  Opinions: 29
  Target Price (avg/high/low): $608.26 / $740.00 / $378.00

### Recent Earnings Analysis
| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-10-22 | $1.98 | $2.51B |
| 2025-07-23 | $1.84 | $2.44B |
| 2025-04-23 | $1.95 | $2.25B |
| 2024-10-18 | $1.59 | $2.04B |
| 2025-10-22 | $1.59 | $2.04B |

### Revenue and Profitability:
| Quarter | Revenue | Profit Margin |
|---------|---------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |

### Capital and Profitability:
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |

### Comprehensive Analysis
Intuitive Surgical's stock performance has been mixed in recent years, despite strong revenue growth. The company's profit margin has also expanded, but its equity and ROE have remained relatively stable. Analysts' opinions are generally positive, with a target price of $608.26 and a mean rating of ~Buy. However, recent news and significant events suggest a potential decline in the stock price despite strong Q4 procedure growth and revenue beat.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.